Volume 2, Issue 18, 05/04/2010
How does aluminum hydroxide chelate with and reduce the intestinal absorption of the fluoroquinolone antibiotic, levofloxacin (Levaquin)?
Aluminum hydroxide Al(OH)3 is a common ingredient in many over-the-counter (OTC) oral antacid medications. It is also used in the short-term as an oral phosphate binder in patients with hyperphosphatemia secondary to chronic kidney disease. When using aluminum based products as an antacid, the short duration of action requires frequent administration throughout the day. Due to its availability OTC, the route, the frequency of administration throughout the day, and the recognition that many people prefer to take all of their medications at the same time, it is plausible that the introduction of levofloxacin (Levaquin) for the treatment of a bacterial infection could be met with the presence of a di- or tri-valent cation, such as aluminum. The coadministration of levofloxacin and aluminum hydroxide can result in a reduction in the overall absorption and bioavailability of levofloxacin thus increasing the risk of the patient either developing bacterial drug resistance and/or treatment failure.1
How does aluminum
specifically interact with levofloxacin to cause a reduction in absorption or
bioavailability?
A basic evaluation
of the chemical structure of levofloxacin reveals that each levofloxacin
molecule has...
.......To read the full answer please LOGIN or SUBSCRIBE NOW.

Copyright 2012 Pharmacology Weekly, Inc. All Rights Reserved. |
